低剂量动态CZT-SPECT心肌灌注显像识别阻塞性冠心病
本研究对173例疑似或已知冠心病患者行低剂量动态CZT-SPECT,测定心肌血流量(MBF)和心肌灌注储备(MPR),并在91例有冠状动脉造影资料的患者中分析动态指标预测阻塞性冠心病(≥70%狭窄)的能力。结果显示阻塞性冠心病患者充血MBF和MPR较低,多因素分析仅MPR为独立预测因子。
要点
- 低剂量动态CZT-SPECT可测定MBF和MPR,MPR与心肌灌注显像结果弱相关(r=-0.179)。
- 阻塞性冠心病患者充血MBF和MPR均低于无阻塞性冠心病者。
- 多因素分析中仅MPR是阻塞性冠心病的独立预测因子。
核心结论
- 在疑似或已知冠心病患者中,低剂量动态CZT-SPECT测定的MPR与心肌灌注显像结果相关性良好,可能有助于预测阻塞性冠心病。
研究设计与样本
- 单中心研究,纳入173例疑似或已知冠心病患者,静息和负荷分别注射155 MBq和370 MBq的99mTc-sestamibi行动态CZT-SPECT。
- 其中91例有冠状动脉造影资料,阻塞性冠心病定义为冠状动脉造影狭窄≥70%。
主要发现
- 心肌灌注显像异常者整体MPR低于正常者(2.40±0.7 vs. 2.70±0.8,p<0.05)。
- 总灌注缺损(TPD)与MPR呈弱但显著负相关(r=-0.179,p<0.05)。
- 91例造影患者中,阻塞性冠心病组(n=21)充血MBF(2.59±1.2 vs. 3.24±1.1 ml/min/g)和MPR(1.96±0.7 vs. 2.74±0.9)均低于无阻塞性冠心病组(n=70),两者p<0.05。
- 单因素分析中TPD、充血MBF和MPR均为阻塞性冠心病的显著预测因子,多因素分析仅MPR为独立预测因子(p<0.05)。
- 按血管分析,31支阻塞性病变血管的局部充血MBF(2.59±1.2 vs. 3.24±1.1 ml/min/g)和局部MPR(1.96±0.7 vs. 2.74±0.9)低于242支无阻塞性病变血管(两者p<0.05)。
关键数值与推荐
- 总灌注缺损(TPD)<5%视为正常。
- 阻塞性冠心病定义为冠状动脉造影狭窄≥70%。
- 静息和负荷动态扫描分别注射155 MBq和370 MBq的99mTc-sestamibi。
临床怎么用
- 对疑似或已知冠心病患者,可考虑采用低剂量动态CZT-SPECT方案同时评估心肌灌注和MPR。
- MPR可能作为识别阻塞性冠心病的独立预测指标,尤其当灌注显像结果不明确时。
局限性
- 仅91例患者有冠状动脉造影资料,样本量有限。
- 原文未报告研究的其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We measured myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) by a dynamic low-dose CZT-SPECT protocol in patients with suspected or known coronary artery disease (CAD) and investigated the capability of dynamic data in predicting obstructive CAD. A total of 173 patients with suspected or known CAD underwent dynamic CZT-SPECT after the injection of 155 MBq and 370 MBq of 99mTc-sestamibi for rest and stress imaging, respectively. Standard rest and stress imaging were performed at the end of each dynamic scan. A total perfusion defect (TPD) < 5% were considered normal. Obstructive CAD was defined as ≥ 70% stenosis at coronary angiography. RESULTS: Global MPR was lower (p < 0.05) in patients with abnormal compared with those with normal MPI (2.40 ± 0.7 vs. 2.70 ± 0.8). A weak, albeit significant correlation between TPD and MPR (r = - 0.179, p < 0.05) was found. In 91 patients with available angiographic data, hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower (both p < 0.05) in patients with obstructive CAD (n = 21) compared with those without (n = 70). At univariable analysis, TPD, hyperemic MBF, and MPR were significant predictors of obstructive CAD, whereas only MPR was independent predictor at multivariable analysis (p < 0.05). At per vessels analysis, regional hyperemic MBF (2.59 ± 1.2 vs. 3.24 ± 1.1 ml/min/g) and regional MPR (1.96 ± 0.7 vs. 2.74 ± 0.9) were lower in the 31 vessels with obstructive CAD compared with 242 vessels without (both p < 0.05). CONCLUSIONS: In patients with suspected or known CAD, MPR assessed by low-dose dynamic CZT-SPECT showed a good correlation with myocardial perfusion imaging findings and it could be useful to predict obstructive CAD.
引用
- Acampa W, Assante R, Mannarino T, et al. Low-dose dynamic myocardial perfusion imaging by CZT-SPECT in the identification of obstructive coronary artery disease. Eur J Nucl Med Mol Imaging. 2019. PMID: 31848673. doi:10.1007/s00259-019-04644-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。